-
EP3411088
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3411088
| EP3411088 - IMPLANTABLE MEDICAL PRODUCTS, A PROCESS FOR THE PREPARATION THEREOF, AND USE THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 12.04.2024 Database last updated on 11.05.2024 | |
| Former | The patent has been granted Status updated on 05.05.2023 | ||
| Former | Grant of patent is intended Status updated on 29.09.2022 | ||
| Former | Examination is in progress Status updated on 14.06.2019 | ||
| Former | Request for examination was made Status updated on 09.11.2018 | ||
| Former | The international publication has been made Status updated on 11.08.2017 | ||
| Former | unknown Status updated on 07.02.2017 | Most recent event Tooltip | 12.04.2024 | No opposition filed within time limit | published on 15.05.2024 [2024/20] | Applicant(s) | For all designated states Schierholz, Jörg Michael Andechserstrasse 70 82319 Starnberg / DE | [2018/50] | Inventor(s) | 01 /
see applicant ... | [2018/50] | Representative(s) | dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB Deichmannhaus am Dom Bahnhofsvorplatz 1 50667 Köln / DE | [2018/50] | Application number, filing date | 17701897.5 | 31.01.2017 | [2018/50] | WO2017EP52040 | Priority number, date | EP20160153686 | 01.02.2016 Original published format: EP 16153686 | [2018/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017134049 | Date: | 10.08.2017 | Language: | EN | [2017/32] | Type: | A1 Application with search report | No.: | EP3411088 | Date: | 12.12.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.08.2017 takes the place of the publication of the European patent application. | [2018/50] | Type: | B1 Patent specification | No.: | EP3411088 | Date: | 07.06.2023 | Language: | EN | [2023/23] | Search report(s) | International search report - published on: | EP | 10.08.2017 | Classification | IPC: | A61L27/54, A61L29/16, A61L31/16, A61L33/00, A61L27/34, A61L29/10, A61L31/10 | [2018/50] | CPC: |
A61L31/16 (EP,US);
A61K31/4174 (EP,US);
A61K31/444 (EP,US);
A61K31/496 (EP,US);
A61K31/573 (EP,US);
A61L27/34 (EP,US);
A61L27/54 (EP,US);
A61L29/06 (US);
A61L29/10 (EP,US);
A61L29/16 (EP,US);
A61L31/06 (US);
A61L31/10 (EP,US);
A61L33/0041 (EP,US);
A61L33/04 (US);
A61L2300/216 (US);
A61L2300/404 (US);
A61L2300/406 (EP,US);
A61L2300/41 (EP,US);
A61L2300/416 (EP,US);
A61L2300/42 (EP,US);
A61L2300/424 (US);
A61L2420/02 (US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/50]
| Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | IMPLANTIERBARE MEDIZINISCHE PRODUKTE, VERFAHREN ZU DEREN HERSTELLUNG UND DEREN VERWENDUNG | [2018/50] | English: | IMPLANTABLE MEDICAL PRODUCTS, A PROCESS FOR THE PREPARATION THEREOF, AND USE THEREOF | [2018/50] | French: | PRODUITS MEDICAUX IMPLANTABLES, LEUR PROCEDE DE FABRICATION ET LEUR UTILISATION | [2022/39] |
| Former [2018/50] | PRODUITS MÉDICAUX IMPLANTABLES, LEUR PROCÉDÉ DE PRÉPARATION ET LEUR UTILISATION | Entry into regional phase | 22.08.2018 | National basic fee paid | 22.08.2018 | Designation fee(s) paid | 22.08.2018 | Examination fee paid | Examination procedure | 22.08.2018 | Examination requested [2018/50] | 22.08.2018 | Date on which the examining division has become responsible | 25.03.2019 | Amendment by applicant (claims and/or description) | 18.06.2019 | Despatch of a communication from the examining division (Time limit: M06) | 23.12.2019 | Reply to a communication from the examining division | 11.12.2020 | Despatch of a communication from the examining division (Time limit: M06) | 21.06.2021 | Reply to a communication from the examining division | 30.09.2022 | Communication of intention to grant the patent | 09.02.2023 | Fee for grant paid | 09.02.2023 | Fee for publishing/printing paid | 09.02.2023 | Receipt of the translation of the claim(s) | Opposition(s) | 08.03.2024 | No opposition filed within time limit [2024/20] | Fees paid | Renewal fee | 29.01.2019 | Renewal fee patent year 03 | 29.01.2020 | Renewal fee patent year 04 | 29.01.2021 | Renewal fee patent year 05 | 28.01.2022 | Renewal fee patent year 06 | 26.01.2023 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CZ | 07.06.2023 | HR | 07.06.2023 | PL | 07.06.2023 | RO | 07.06.2023 | RS | 07.06.2023 | SK | 07.06.2023 | SM | 07.06.2023 | NO | 07.09.2023 | GR | 08.09.2023 | IS | 07.10.2023 | [2024/10] |
| Former [2024/08] | HR | 07.06.2023 | |
| RS | 07.06.2023 | ||
| SK | 07.06.2023 | ||
| SM | 07.06.2023 | ||
| NO | 07.09.2023 | ||
| GR | 08.09.2023 | ||
| Former [2023/51] | HR | 07.06.2023 | |
| RS | 07.06.2023 | ||
| NO | 07.09.2023 | ||
| GR | 08.09.2023 | ||
| Former [2023/50] | NO | 07.09.2023 | |
| GR | 08.09.2023 | ||
| Former [2023/48] | NO | 07.09.2023 | Cited in | International search | [XI]US8877882 (SALAMONE JOSEPH CHARLES [US], et al) [X] 1-4,8-10,14,15 * column 7, line 13 - line 17 * * claims 21,24-26 *[I] 5-7,11-13; | [X]WO2016014119 (CORMATRIX CARDIOVASCULAR INC [US]) [X] 1-4,8,9,14,15 * page 10, paragraphs 66,67 * * claims 1,9,12 * | Examination | WO0007574 | WO2008086794 | - Rote Liste, Rote Liste Service GmbH, (20140101), ISBN 978-3-939192-80-0 | by applicant | US4612337 | US4642104 | WO8701595 | WO8703495 | US4677143 | DE3613213 | US4713239 | DE3725728 | WO8904628 | EP0328421 | WO8909626 | EP0350161 | US4999210 | EP0301717 | EP0231573 | WO9201542 | EP0484057 | EP0520160 | WO9410838 | WO9504568 | EP0640661 | US5451424 | EP0470443 | US5525348 | WO9632907 | WO9633670 | WO9639200 | WO9639215 | WO9725085 | US5688516 | WO0007574 | US8877882 | WO2016014119 | - FAC-Fortschritte der antimikrobiellen Chemotherapie, Antibiotikatherapie und Blutgerinnung, FUTURAMED VERLAG, (1984), vol. 3-3 | - NEEDLEMAN ET AL., "Application of imidazole as a selective inhibitor of thromboxane synthetase in human platelets", PROC. NATL. ACAD. SCI. USA, (1977), vol. 74, no. 4, pages 1716 - 1720 | - STEINHILBER D; JASCHONEK K; KNOSPE J; MOROF O; ROTH HJ, "Effects of novel antifungal azole derivatives on the 5-lipoxygenase and cyclooxygenase pathway", ARZNEIMITTELFORSCHUNG, (1990), vol. 40, no. 11, pages 1260 - 3 | - MERTENS RL; MORIAS J; VERHAMME G, "A double-blind study comparing Daktacort, miconazole and hydrocortisone in inflammatory skin infections", DERMATOLOGICA, (1976), vol. 153, no. 4, pages 228 - 35 | - HANADA S; SUGAWARA SH; SERTIE JA, "Miconazole as inflammatory agent. II: Time course of pleurisy and drug interference", GEN PHARMACOL., (1998), vol. 30, no. 5, pages 791 - 4 | - SEYFERT U.T, "Hemocompatibility testing", CLINICAL LABORATORY, (1997), vol. 43, pages 571 - 582 |